Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 21 articles: HTML format

Single Articles

October 2025
1. LAFORCE C, Papi A, Bacharier LB
   As-Needed Albuterol-Budesonide in Mild Asthma. Reply.
   N Engl J Med. 2025;393:1756.
   PubMed    
   
   
   
2. ROLLA G
   As-Needed Albuterol-Budesonide in Mild Asthma.
   N Engl J Med. 2025;393:1755-1756.
   PubMed    
   
   
   September 2025
3. BRADLEY JM, O'Neill B, McAuley DF, Chalmers JD, et al
   Hypertonic Saline or Carbocisteine in Bronchiectasis.
   N Engl J Med. 2025 Sep 28. doi: 10.1056/NEJMoa2510095.
   PubMed     Abstract available
   
   
   July 2025
4. DRAZEN JM
   Your Combination Asthma Inhaler - Don't Leave Home without It!
   N Engl J Med. 2025;393:186-187.
   PubMed    
   
   
   May 2025
5. LAFORCE C, Albers F, Danilewicz A, Jeynes-Ellis A, et al
   As-Needed Albuterol-Budesonide in Mild Asthma.
   N Engl J Med. 2025 May 19. doi: 10.1056/NEJMoa2504544.
   PubMed     Abstract available
   
   
   
6. SCIURBA FC, Criner GJ, Christenson SA, Martinez FJ, et al
   Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
   N Engl J Med. 2025;392:1710-1720.
   PubMed     Abstract available
   
   
   April 2025
7. HILL AT
   Defanging the Neutrophil to Treat Bronchiectasis.
   N Engl J Med. 2025;392:1649-1652.
   PubMed    
   
   
   
8. BELL SC, Grimwood K
   Brensocatib in Bronchiectasis - A New Sheriff in Town?
   N Engl J Med. 2025;392:1647-1648.
   PubMed    
   
   
   
9. CHALMERS JD, Burgel PR, Daley CL, De Soyza A, et al
   Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis.
   N Engl J Med. 2025;392:1569-1581.
   PubMed     Abstract available
   
   
   March 2025
10. HU X
    Emphysematous Vertebral Osteomyelitis.
    N Engl J Med. 2025;392:1017.
    PubMed    
    
    
    September 2024
11. BHATT SP, Rabe KF, Bafadhel M
    Dupilumab for COPD with Elevated Eosinophil Counts. Reply.
    N Engl J Med. 2024;391:1164.
    PubMed    
    
    
    
12. ROLLA G
    Dupilumab for COPD with Elevated Eosinophil Counts.
    N Engl J Med. 2024;391:1163-1164.
    PubMed    
    
    
    
13. EKSTROM M, Andersson A, Papadopoulos S, Kipper T, et al
    Long-Term Oxygen Therapy for 24 or 15 Hours per Day in Severe Hypoxemia.
    N Engl J Med. 2024;391:977-988.
    PubMed     Abstract available
    
    
    
14. TAICHMAN DB, Drazen JM
    Making Long-Term Oxygen Therapy Less Burdensome.
    N Engl J Med. 2024;391:1050-1051.
    PubMed    
    
    
    
15. AARON SD
    Early Diagnosis and Treatment of COPD and Asthma. Reply.
    N Engl J Med. 2024;391:968.
    PubMed    
    
    
    
16. VAN GEFFEN WH, van der Meer AN
    Early Diagnosis and Treatment of COPD and Asthma.
    N Engl J Med. 2024;391:967-968.
    PubMed    
    
    
    
17. JACKSON DJ, Wechsler ME, Jackson DJ, Bernstein D, et al
    Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype.
    N Engl J Med. 2024 Sep 9. doi: 10.1056/NEJMoa2406673.
    PubMed     Abstract available
    
    
    July 2024
18. ASSAD Z, Romain AS, Aupiais C, Shum M, et al
    Nirsevimab and Hospitalization for RSV Bronchiolitis.
    N Engl J Med. 2024;391:144-154.
    PubMed     Abstract available
    
    
    June 2024
19. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
    Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.
    N Engl J Med. 2024;390:2274-2283.
    PubMed     Abstract available
    
    
    
20. DIAO JA, He Y, Khazanchi R, Nguemeni Tiako MJ, et al
    Implications of Race Adjustment in Lung-Function Equations.
    N Engl J Med. 2024;390:2083-2097.
    PubMed     Abstract available
    
    
    May 2024
21. AARON SD, Vandemheen KL, Whitmore GA, Bergeron C, et al
    Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial.
    N Engl J Med. 2024 May 19. doi: 10.1056/NEJMoa2401389.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.